Humana Inc.'s senior management team is scheduled to meet with investors and analysts at various meetings between March 2, 2026, and March 31, 2026. The company intends to reaffirm its guidance for the year ending December 31, 2026 (FY 2026). The reaffirmed guidance includes diluted earnings per common share (EPS) of at least $8.89 and adjusted earnings per common share (Adjusted EPS) of at least $9.00. This guidance is consistent with the guidance previously issued in a press release dated February 11, 2026. Adjusted (non-GAAP) EPS is presented as a measure management believes provides a comprehensive perspective for comparing and analyzing the company's core operating performance over time, and is used for planning, decision-making, and incentive compensation. The company does not expect changes to its FY 2026 Adjusted (non-GAAP) EPS guidance. Potential changes to FY 2026 GAAP EPS guidance are expected due to ongoing value creation and other strategic initiatives.